Brief: Aptevo Therapeutics Inc - Marvin White To Retire As Aptevo CEO Effective April 1, 2026 - SEC Filing
03/02/2026 13:37
Feb 3 (Reuters) - Aptevo Therapeutics Inc APVO.O: APTEVO THERAPEUTICS INC - MARVIN WHITE TO RETIRE AS APTEVO CEO EFFECTIVE APRIL 1, 2026 - SEC FILING APTEVO THERAPEUTICS INC - JEFF LAMOTHE TO BECOME APTEVO CEO; MARVIN WHITE EXECUTIVE CHAIR - SEC FILING Source text: [ID:n0001193125-26-034473] Further company coverage: APVO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary